Zeon Corporation Acquires Edge Precision Manufacturing Inc ("Edge"), a leading manufacturer of micro featured thermoplastic devices for diagnostic, clinical, optics, and research applications
10 Jan 2023
Acquisition
Innovative Materials meets High Precision Micro-Manufacturing,
Accelerating the Development of Healthcare and Life Sciences Business
TOKYO, Jan. 9, 2023 /PRNewswire/ -- Zeon Corporation (Zeon; head office: Chiyoda-ku, Tokyo; President and CEO: Kimiaki Tanaka), through its subsidiary Zeon Specialty Materials Inc. (California, U.S.A.; representative: Hirokazu Matsumoto), has purchased 100% of the shares of Edge Precision Manufacturing, Inc. (Massachusetts, U.S.A.; representative: Andrew Kamholz), a manufacturer of micro featured thermoplastic devices, from shareholders including venture capital funds managed by U.S. investment company Anzu Partners, LLC, on December 28, 2022.
Continue Reading
"The combination of Edge and ZEON offers our customers unprecedented security with a simplified supply chain underpinned by the parent company's long-term track record of growth and success," said Edge's CEO Andrew Kamholz, Ph.D., "Edge can now further optimize both its proprietary thermal compression tooling and scale manufacturing technologies, offering the only product-quality process that requires no bridge tooling between prototyping and large-volume production."
"The combination of Edge and ZEON offers our customers unprecedented security with a simplified supply chain underpinned by the parent company's long-term track record of growth and success"
Tweet this
ZEON's COPs (product names ZEONEX® and ZEONOR®), well known for their unique properties such as low autofluorescence, high light transmittance, low biomolecules adsorption, low impurities, and low melt viscosity, have been the leading material used for microscale and microfluidic and biochemical analysis applications
Through the acquisition of Edge, which uses many of ZEON's materials, ZEON will strengthen COP's use for microfluidic analytical devices while leveraging EDGE's customer network, including that of Aurora Microplates for microplates, acquired in February 2022. This latest move by ZEON aims at developing new businesses for cyclo olefin polymers (COPs) while expanding their commitment to explore new businesses in healthcare and life sciences
Outline of Edge
Company Name: Edge Precision Manufacturing, Inc
Business: Manufacturer of custom micro-featured thermoplastic disposables for diagnostic, clinical, optics, and research applications featuring high definition and high aspect ratio based on proprietary compression molding technology
Representative: Andrew Kamholz-CEO
Address: 12 Dunham Rd Billerica Suite 4, Massachusetts 01821, U.S.A.
URL: www.edgeprecision.com
Outline of Anzu Partners
Company Name: Anzu Partners, LLC
Business: Investment firm specializing in investing in technologies with the potential to transform industries
Representative: David Seldin-Managing Partner
Address: 12610 Race Track Road, Tampa, FL 33626, U.S.A.
URL: www.anzupartners.com
Outline of Zeon Specialty Materials
Company Name: Zeon Specialty Materials Inc.
Business: Marketing and sales base for specialty materials established to provide a swift response to customer needs in North America
Representative: Hirokazu Matsumoto- President
Address: 25 Metro Drive, Suite 238, San Jose, California 95110, U.S.A.
URL: www.zeonsmi.com
SOURCE ZEON
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.